Biotechnology and biochemical weapons

Nonproliferation Review

Volumn 9, Issue 1, 2002, Pages 48-53

  Wheelis, Mark ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84988893339     PISSN: 10736700     EISSN: 17461766     Source Type: Journal    
DOI: 10.1080/10736700208436873     Document Type: Article

References (21)

1. Claire M. Fraser and Malcolm R. Dando, “Genomics and Future Biological Weapons: The Need for Preventive Action by the Biomedical Community,” Nature Genetics 29 (2001), pp. 253-256
2. Mark Wheelis and Malcolm Dando, “New Technology and Future Developments in Biological Warfare,” Disarmament Forum 4 (2000), pp. 43-50.
3. ‘Jonathan Ellman, Barry Stoddard, and Jim Wells, “Combinatorial Thinking in Chemistry and Biology,” Proceedings of the National Academy of Sciences (USA) 94 (1997), pp. 2779-2782.
4. Dr. Lynn Klotz for helpful suggestions. An earlier version of this paper was delivered at the Pugwash Conferences on Science and World Af­fairs, Workshop on the Implementation of the Chemical and Biological Weap­ons Conventions, Oegstgeest, Netherlands, June 2001.
5. Ronald E. White, “High-Throughput Screening in Drug Metabolism and Pharmacokinetic Support of Drug Discovery,” Annual Review of Pharmacology and Toxicology 40 (2000), pp. 133-157.
6. Kollol Pal, “The Keys to Chemical Genomics,” Modern Drug Discovery 3 (2000), pp. 47-55.
7. Tamas Bartfai, “Genomic Identification of Receptors and Their Polymorphisms, and Ligand Design,” in Malcom Dando, Graham Pearson, and Bohumir Kriz, eds., New Scientific and Technical Developments of Relevance to the Biological and Toxin Weapons Convention (forthcoming).
8. David J. Lockhart and Elizabeth A. Winzler, “Genomics, Gene Expression and DNA Arrays,” Nature 405 (2000), 827-836.
9. Akhilesh Pandey and Matthias Mann, “Proteomics to Study Genes and Genomes,” Nature 405 (2000), 837-846
10. Rosamonde E. Banks etal., “Proteomics: New Perspectives, New Biomedical Opportunities,” Lancet 356 (2000), pp. 1749-1756.
11. John R. Yates, “Mass Spectrometry: from Genomics to Proteomics,” Trends in Genetics 16 (2000), pp. 5-8.
12. Heng Zhu et al., “Global Analysis of Protein Activities Using Proteome Chips,” Science 293 (2001), pp. 2101 -2105.
13. David Baker and Andrej Sali, “Protein Structure Prediction and Structural Genomics,” Science 294 (2001), pp. 93-96.
14. Jeffery F. Waring and Roger G Ulrich, “The Impact of Genomics-Based Technologies on Drug Safety Evaluation,” Annual Review of Pharmacology and Toxicology 40 (2000), pp. 335-352.
15. Ajay, W. Patrick Walters, and Mark A. Murko, “Can We Leam to Distinguish between ‘Drug-Like’ and ‘Nondrug-Like’ M olecules?” Journal of Medicinal Chemistry 41 (1998), pp. 3314-3324
16. Jens Sadowski and Hugo Kubinyi, “A Scoring Scheme for Discriminating between Drugs and Nondrugs,” Journal of Medicinal Chemistry 41 (1998), pp. 3325-3329.
17. Margaret-Anne Coppermoll and Xavier K. Maruyama, “Legal and Ethical Guiding Principles and Constraints Concerning Non-Lethal Weapons Te chnology and Employment,” Presentation at the Non-Lethal Defense III Symposium in 1998, Defense Technical Information Center, .
18. Non-Lethal Weapons Research in the US: Calmatives and Maloderants” and “Non-Lethal Weapons Research in the US: Genetically Engineered Anti-Material Weapons,” .
19. Malcolm Dando, A New Form of Warfare: The Rise ofNon-Lethal Weapons (Washington DC: Brassey’s, 1966).
20. George W. Parshall, “Scientific and Technical Developments and the CWC,” in Jonathan B. Tucker, ed., The Chemical Weapons Convention: Implementation Challenges and Solutions (Washington DC: Monterey Institute of International Studies, 2001), pp 53-58
21. The Convention on the Prohibition of the Development, Production, Stockpiling and Use of Chemical Weapons and on Their Destruction opened for signature in Paris on January 13,1993, and entered into force on April 29,1997.